Oceania Capital Partners

Oceania Capital Partners is a public company listed on the Australian Securities Exchange, not a closed-end private equity fund. This permanent-capital structure means it has no fixed fund life and no obligation to return capital to limited partners on a predetermined schedule, so it can hold portfolio companies indefinitely. The model is uncommon among Australian private-equity managers and provides flexibility to structure deals as minority partnerships alongside founders.

The firm's stated preference is to partner existing owners by taking meaningful, often non-controlling stakes. However, its portfolio includes both majority and minority positions: it acquired a majority stake in Crimsafe while investing alongside management, and minority stakes in Puremedic Health and Sports Entertainment Network. The structure varies by transaction, but the franchise is built around backing founder-led businesses rather than installing new management.

Oceania Capital Partners has invested across consumer goods (Boody, Puremedic Health), civil infrastructure (AusConnect), data and identity verification (WINR), security products (Crimsafe), and sports media (Sports Entertainment Network). The firm does not publish explicit sector restrictions, but its portfolio shows a bias toward businesses with global growth potential and recurring demand rather than speculative technology or resource-extraction plays.

Yes. While the firm is headquartered in Australia, its portfolio companies sell into the United States, New Zealand, the United Kingdom and Europe. Crimsafe operates in the US, Boody distributes across the UK, Europe, New Zealand and the US, and the firm's corporate footprint has previously included a Sausalito, California office according to some commercial records.

The firm does not publicly name individual investment professionals on its website, describing its team only as 'a team of experienced investment professionals.' As an ASX-listed entity, ultimate investment authority resides with the board, but no publicly available source identifies the specific CIO, managing partner, or investment committee members as of the latest research record.